




Searching News Database: Valentis
HSMN NewsFeed - 21 Aug 2007
Inovio Biomedical Appoints Dr. Michael Fons as Vice President, Corporate Development
Inovio Biomedical Appoints Dr. Michael Fons as Vice President, Corporate Development
HSMN NewsFeed - 30 Jul 2007
Urigen Pharmaceuticals, Inc., formerly Valentis, Inc. Announces Name Change and New Stock Symbol
Urigen Pharmaceuticals, Inc., formerly Valentis, Inc. Announces Name Change and New Stock Symbol
HSMN NewsFeed - 4 Apr 2007
Threshold Pharmaceuticals Appoints David R. Hoffmann to Board of Directors
Threshold Pharmaceuticals Appoints David R. Hoffmann to Board of Directors
HSMN NewsFeed - 8 Jan 2007
Urigen N.A., Inc. Appoints Dennis Giesing, PhD As Director of Product Development
Urigen N.A., Inc. Appoints Dennis Giesing, PhD As Director of Product Development
HSMN NewsFeed - 17 Oct 2006
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis
HSMN NewsFeed - 29 Sep 2006
Celsion Obtains from Valentis Exclusive Rights to Pegylation Patents for use with Heat Activated Liposomes
Celsion Obtains from Valentis Exclusive Rights to Pegylation Patents for use with Heat Activated Liposomes
Additional items found! 15

Members Archive contains
15 additional stories matching:
Valentis
(Password required)
Valentis
(Password required)